SLN Alone in High-Risk Endometrial Cancer with Vito Andrea Capozzi

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Vito Andrea Capozzi to discuss SLN alone in high-risk endometrial cancer. Dr. Capozzi works at the Department of Medicine and Surgery of the University Hospital of Parma, Italy. He shows special interest in gynecologic oncology, oncologic surgery, and translational medicine.

Highlights:

1. Sentinel lymph node mapping alone in high-risk endometrial cancer patients is an oncologically safe technique over a median observational time of 31 months.
2. No significant difference in overall survival and disease-free survival was observed between sentinel lymph node alone and Lymphadenectomy groups.
3. Patients with histologically proven nodal metastasis had overlapping survivals and disease-free survival in the sentinel lymph node alone and lymphadenectomy groups.